Stocks to buy under ₹100: Sumeet Bagadia recommends three shares to buy on Monday – 12 April 2025

Stocks to buy under 100: The Indian stock market ended its longest weekly winning streak of 2025 due to escalating geopolitical tensions between India and Pakistan, which weighed on investor confidence and pulled the indices down. Domestic equity benchmarks, the Sensex and Nifty 50, saw heightened volatility amid the border conflict.

Over the week, the BSE benchmark declined by 1,047.52 points or 1.30%, while the Nifty lost 338.7 points or 1.39%. The main equity indices experienced significant declines this week, largely due to rising geopolitical tensions between India and Pakistan amid reports of drone and missile strikes.

Sumeet Bagadia’s stock recommendations

Sumeet Bagadia, Executive Director at Choice Broking, believes that the Indian stock market sentiment has turned cautious as the Nifty 50 index has closed below 50-DEMA support placed at 24,050.

Speaking on the outlook of Indian stock market, Bagadia said, “ The benchmark index support has now slipped around 23,800 levels. On the upper side, the 50-stock index is facing hurdle at 23,400. So, one should maintain stock-specific approach and look at those stocks that are looking strong on the technical chart.”

Regarding stocks to buy under 100, Sumeet Bagadia recommended buying these three shares: Silgo Retail, Lotus Eye Hospital and Institute, and Cupid.

Stocks to buy under 100

1] Silgo Retail: Momentum buy at 49.35, Stop Loss of 47.5; Target Price of 53.

2] Lotus Eye Hospital and Institute: Momentum buy at 73.34, Stop Loss of 70.5; Target Price of 78.5.

3] Cupid: Momentum buy at 84.13, Stop Loss of 81; Target Price of 90.

Disclaimer: The views and recommendations provided in this analysis are those of individual analysts or broking companies, not Mint. We strongly advise investors to consult with certified experts before making any investment decisions, as market conditions can change rapidly and individual circumstances may vary.

Related Content

Leave a Comment